Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,467 public trials 2,848 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I

NCT02553460

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's Hospital and Clinics of Minnesota Minneapolis, Minnesota, United States
View all 15 locations
View Trial Details
Active, not recruiting

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

NCT01594723

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +3 more
Locations
  • Highlands Oncology Group - Duplicate 2 Rogers, Arkansas, United States
  • Providence St. Joseph's Medical Center Burbank, California, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
  • Lakeland Regional Cancer Center Lakeland, Florida, United States
View all 39 locations
View Trial Details
Active, not recruiting

Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia

NCT03289910

Conditions
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid Leukemia, +32 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Active, not recruiting

A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)

NCT05031780

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of California San Diego La Jolla, California, United States
  • UCLA Health Los Angeles, California, United States
  • Children's Hospital Oakland Oakland, California, United States
  • University of Connecticut Health Center Farmington, Connecticut, United States
View all 91 locations
View Trial Details

Related conditions